Achievement of Clinical, Endoscopic, and Histological Outcomes in Patients with Ulcerative Colitis Treated with Etrasimod, and Association with Faecal Calprotectin and C-reactive Protein: Results From the Phase 2 OASIS Trial

By sjmartinez • June 4, 2024

Yarur AJ, Chiorean MV, Panés J, Jairath V, Zhang J, Rabbat CJ, Sandborn WJ, Vermeire S, Peyrin-Biroulet L. Achievement of Clinical, Endoscopic, and Histological Outcomes in Patients with Ulcerative Colitis Treated with Etrasimod, and Association with Faecal Calprotectin and C-reactive Protein: Results From the Phase 2 OASIS Trial. J Crohns Colitis. 2024 Jun 3;18(6):885-894. doi: 10.1093/ecco-jcc/jjae007. PMID: 38245818; PMCID: PMC11147797.

Tags: Cedars Sinai DoM, Digestive Diseases, endoscopic improvement–histologic remission, Etrasimod, mucosal healing, Publications, S1P receptor modulator, ulcerative colitis

All-in-One Cardiac MRI: Unified Non-Contrast-enhanced and Contrast-enhanced Imaging for a Continuous-Acquisition Examination

Mao X, Chen Z, Hu Z, Lee HL, Kwan AC, Cokic I, Cao T, Han F, Xie Y, Li D, Christodoulou AG. All-in-One Cardiac MRI:[...]

Minimum standards for training in colorectal endoscopic mucosal resection among advanced endoscopy trainees

Yang D, Robalino Gonzaga E, Hasan MK, Trindade AJ, Radlinski M, Burbridge RA, Mosko J, Taunk P, Jawaid S, Othman MO, Diehl DL, Khara HS,[...]

Treatment Response to Mavacamten in Patients With Obstructive Hypertrophic Cardiomyopathy: 96-Week Results From the EXPLORER Cohort of the MAVA-Long-Term Extension Cardiac Magnetic Resonance Imaging Substudy

Saberi S, Kramer CM, Oręziak A, Masri A, Barriales-Villa R, Abraham TP, Lakdawala NK, Wang A, Choudhury L, Rader F, Havakuk O, Stendahl JC, Cardim[...]